Clinical trials
Myocardial Injury clinical trials
Below are recruiting myocardial injury clinical trials, each written for real people, not researchers. We’re tracking 44 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07725185Enrolling by invitation
Can remimazolam protect heart health during surgery?
This study tests whether a sedative called remimazolam can help protect the heart during surgery in older adults. If you are 65 or older and having a longer surgery with general anesthesia, this trial may be for you.
Jiaxing, ZhejiangAges 65 years+ - NCT04465591Recruiting
Study of troponin fragments after heart muscle injury
This study looks at a specific lab pattern (“troponin fragmentation”) in blood samples taken from people after a heart muscle injury. It may help researchers understand the injury better and improve how it’s measured.
Turku, Southwest FinlandAges 18 years+ - NCT04750616RecruitingPhase 2
NAD+ for heart injury prevention around non-emergency surgery
This Phase 2 trial studies whether adding NAD+ can reduce heart muscle injury around scheduled heart surgery. It may help protect the heart (and possibly kidneys) in people considered higher risk for complications.
San Francisco, CaliforniaAges 18 years+ - NCT06279000RecruitingPhase 3
Colchicine for heart risk during major non-heart surgery
This study tests whether a low-cost, anti-inflammatory drug called colchicine can reduce heart complications after major non-heart surgery. If you have heart or blood vessel risk factors and are scheduled for a major operation, this trial may help protect your heart.
Sankt Gallen, Canton of St. GallenAges 45 years+ - NCT06343259Recruiting
Comparing anesthesia types for hip surgery in older adults
This study compares general anesthesia (you are completely asleep) versus spinal anesthesia (you are awake but numb from the waist down) during hip surgery to see which one is better at preventing heart muscle damage. It is for people 65 and older who are at moderate to high risk for heart problems.
IstanbulAges 65 years+ - NCT06564909RecruitingPhase 2
L-carnitine for heart muscle protection after a heart attack
This trial tests whether the supplement L-carnitine, given during a heart attack procedure, can reduce heart muscle damage. If you are having a STEMI heart attack and are getting angioplasty, you may be able to join.
CairoAges 18–75 - NCT05519735Recruiting
Heart MRI study after a heart attack treated by catheter
This study looks at the lymphatic system and heart tissue after a heart attack (STEMI) in people who had prompt catheter treatment. It uses heart MRI to understand healing and may help researchers improve care after a heart attack.
WürzburgAges 18–90 - NCT05198791RecruitingPhase 2
Eplerenone for heart injury without blocked heart arteries
This Phase 2 study tests whether eplerenone can improve outcomes after a heart attack (or similar heart injury) when coronary angiography shows no blocked heart arteries. It focuses on people with added cardiovascular risk factors and evaluates how well the treatment works for heart recovery and strain on the heart.
East Kilbride, LanarkshireAges 18 years+ - NCT06324461RecruitingPhase 4
GLP-1 drug to protect heart after non-emergency surgery
This study tests whether a GLP-1 receptor agonist (a medication used for diabetes and weight loss) can reduce heart damage during or after planned non-cardiac surgery. It may help patients with heart risk undergoing intermediate to high-risk procedures.
Hong Kong, Hong Kong SARAges 18 years+ - NCT06296212RecruitingPhase 3
Testing TAD injection to protect the heart during pneumonia
This trial tests if a medicine called TAD® (glutathione injection) can help prevent heart injury in people hospitalized with pneumonia. It is for patients who also have heart risks or conditions, and takes place in the hospital.
Pisa, PIAges 18–80 - NCT06567249Recruiting
Cooling the heart during a heart attack procedure
This study tests whether cooling the heart with a cold liquid during a procedure (angioplasty) can help reduce damage after a heart attack. It may be an option for people who arrive at the hospital quickly after a heart attack.
TomskAges 18–90 - NCT07100457Recruiting
OR6A2 on immune cells and heart recovery after heart attack
This study looks at a molecule called OR6A2 on certain immune cells (monocytes) in people who have had a heart attack treated with a stent. It aims to see if this molecule is linked to heart recovery and future heart problems.
Nanjing, JiangsuAges 18–90 - NCT07179029Recruiting
Can anesthesia affect the heart during non-cardiac surgery?
This study looks at whether anesthesia can cause heart damage during non-cardiac surgeries. If you have certain health risks, participating may help doctors learn how to better protect your heart.
TübingenAges 40–80 - NCT06128993Recruiting
cooling the heart during heart attack treatment
This trial tests a new way to protect the heart during emergency angioplasty by gently cooling the heart with a cold fluid. It may help reduce damage from a heart attack if you are treated within 12 hours.
UxbridgeAges 18 years+ - NCT07634666Recruiting
Heart Safety Monitoring During Urologic Cancer Surgery
This study tracks heart health before and after major surgery for prostate or kidney cancer in older adults. Researchers want to predict which patients might experience heart problems after surgery so they can provide better care.
SeoulAges 60 years+ - NCT07168421RecruitingPhase 4
Landiolol to prevent fast heart rate during major surgery
This trial tests a short-acting medicine called landiolol to see if it can prevent dangerously fast heart rates during and after major surgery. It is for people who have heart risks and are having a planned non-cardiac surgery.
BernAges 45 years+ - NCT06759818Enrolling by invitation
Vagus nerve stimulation for heart protection after lung surgery in older adults
This trial tests if a gentle ear stimulation device can protect the heart after lung surgery in patients aged 60 and older. It is for those having a planned lung procedure (lobectomy, segmentectomy, or wedge resection) through small chest incisions.
Jiaxing, ZhejiangAges 60 years+ - NCT05635877RecruitingPhase 4
Low-dose heart-rate medicine after surgery in frail older adults
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
Jinan, ShandongAges 65–90 - NCT07028593RecruitingPhase 4
Ciprofol for heart protection during lung surgery
This trial tests if a new sedative drug, Ciprofol, can reduce heart damage after non-cardiac surgery compared to standard care. It is for people aged 45–80 having planned lung surgery (like lobe removal or wedge resection) who will stay in the hospital for at least 3 days after the procedure.
WuhanAges 40–80 - NCT06291714Recruiting
Non-invasive blood pressure prediction during major surgery
This trial tests a new, non-invasive way to predict drops in blood pressure during major hip, knee, pelvis, or spine surgery. The goal is to help doctors prevent low blood pressure, which can lead to complications.
GiessenAges 45 years+ - NCT07362446RecruitingPhase 2
Study of a heart drug for first-time heart attack patients
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Kingswood, New South WalesAges 40–75 - NCT06506071Recruiting
Advanced CT scan for recent heart damage
This study uses advanced CT scans to better understand different types of acute heart muscle damage, such as heart attacks without blocked arteries, inflammation, or stress-related damage. It may help your doctors get clearer images of your heart to guide your treatment.
SalamancaAges 18 years+ - NCT06802224RecruitingPhase 4
Medication to prevent kidney injury after major surgery
This study compares two medications given during surgery to see which one better protects the kidneys after the procedure. If you are having major non-cardiac surgery that lasts at least 2 hours and you need medication to support your blood pressure, this trial may be a good fit.
San Francisco, CaliforniaAges 18 years+ - NCT07023679Recruiting
Stellate ganglion shot with morphine for heart attack patients
This study tests if a painkiller (morphine) injected near certain neck nerves can reduce damage to the heart muscle during a heart attack procedure. It is for people having a specific type of heart attack and who will get a stent to open the blocked artery.
HefeiAges 18 years+
Hear when a new Myocardial Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial injury?
- Yes. Clin2 currently lists 44 recruiting myocardial injury studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial injury trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial injury trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.